US backs Pfizer's low-dose COVID-19 vaccine for kids, FDA approval expected soon

A Food and Drug Administration advisory panel voted unanimously, with one abstention, that the vaccine's benefits in preventing COVID-19 in that age group outweigh any potential risks including a heart-related side effect that's been very rare in teens and young adults despite their use of a much higher shot dose.